Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 10, 2020

Total Value ($000): $262,045 (100.0% shares, 0.0% debt)

Holdings (13)

BBIO BridgeBio (BBIO) 49.6%

Value ($000) $130,095 Shares 3,989,412 Est. Cost $27.40 Unrealized +11.1%

— Eidos Therapeutics, Inc. (EIDIX) 20.4%

Value ($000) $53,563 Shares 1,123,630 Est. Cost $13.76 Unrealized —

— AVROBIO, Inc. (AVRO) 6.7%

Value ($000) $17,621 Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Aeglea Biotherapeutics Inc (AGLE) 6.0%

Value ($000) $15,643 Shares 1,691,151 Est. Cost $8.00 Unrealized —

SNDX Syndax Pharmaceuticals Inc. (SNDX) 5.8%

Value ($000) $15,191 Shares 1,025,000 Est. Cost $10.24 Unrealized +48.7%

— Atreca (BCEL) 3.1%

Value ($000) $8,249 Shares 387,653 Est. Cost $18.84 Unrealized —

— ObsEva SA (OBSV) 3.1%

Value ($000) $8,166 Shares 1,386,338 Est. Cost $12.66 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 1.6%

Value ($000) $4,140 Shares 2,000,000 Est. Cost $5.55 Unrealized —

— Sunesis Pharmaceuticals, Inc. (SNSS) 1.0%

Value ($000) $2,660 Shares 10,100,000 Est. Cost $0.89 Unrealized —

— Zosano Pharma Corporation (ZSAN) 0.9%

Value ($000) $2,328 Shares 2,718,226 Est. Cost $2.15 Unrealized —

— Verona Pharma plc (VRNA) 0.8%

Value ($000) $2,072 Shares 443,596 Est. Cost $9.65 Unrealized —

— Nabriva Therapeutics plc (NBRV) 0.5%

Value ($000) $1,289 Shares 1,910,287 Est. Cost $1.49 Unrealized —

ACRS Aclaris Theraputics Inc (ACRS) 0.4%

Value ($000) $1,028 Shares 634,455 Est. Cost $10.31 Unrealized -87.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio (BBIO)	3,989,412	$130,095	49.6%	$27.40	+11.1%	COM	10806X102
—	Eidos Therapeutics, Inc. (EIDIX)	1,123,630	$53,563	20.4%	$13.76	—	COM	28249H104
—	AVROBIO, Inc. (AVRO)	1,009,779	$17,621	6.7%	$16.72	—	COM	05455M100
—	Aeglea Biotherapeutics Inc (AGLE)	1,691,151	$15,643	6.0%	$8.00	—	COM	00773J103
SNDX	Syndax Pharmaceuticals Inc. (SNDX)	1,025,000	$15,191	5.8%	$10.24	+48.7%	COM	87164F105
—	Atreca (BCEL)	387,653	$8,249	3.1%	$18.84	—	CL A COM	04965G109
—	ObsEva SA (OBSV)	1,386,338	$8,166	3.1%	$12.66	—	COM	H5861P103
—	Marker Therapeutics, Inc. (MRKR)	2,000,000	$4,140	1.6%	$5.55	—	COM	57055L107
—	Sunesis Pharmaceuticals, Inc. (SNSS)	10,100,000	$2,660	1.0%	$0.89	—	COM	867328700
—	Zosano Pharma Corporation (ZSAN)	2,718,226	$2,328	0.9%	$2.15	—	COM	98979H202
—	Verona Pharma plc (VRNA)	443,596	$2,072	0.8%	$9.65	—	COM	925050106
—	Nabriva Therapeutics plc (NBRV)	1,910,287	$1,289	0.5%	$1.49	—	SHS	G63637105
ACRS	Aclaris Theraputics Inc (ACRS)	634,455	$1,028	0.4%	$10.31	-87.0%	COM	00461U105